Corcept Therapeutics Inc
NASDAQ:CORT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
US |
|
T
|
Thai Beverage PCL
OTC:TBVPY
|
TH |
|
Deterra Royalties Ltd
ASX:DRR
|
AU |
|
S
|
Schnitzer Steel Industries Inc
F:SS1A
|
US |
|
P
|
Patel Engineering Ltd
BSE:531120
|
IN |
|
Zurich Insurance Group AG
F:ZFI1
|
CH |
|
N
|
Nimbus Group AB (publ)
STO:BOAT
|
SE |
|
I
|
International Business Machines Corp
LSE:IBM
|
US |
|
Duluth Holdings Inc
NASDAQ:DLTH
|
US |
|
Upstart Holdings Inc
NASDAQ:UPST
|
US |
|
Apollo Medical Holdings Inc
NASDAQ:ASTH
|
US |
|
BWX Technologies Inc
NYSE:BWXT
|
US |
|
Bank Rakyat Indonesia (Persero) Tbk PT
OTC:BKRKY
|
ID |
Bankruptcy Probability
Corcept Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Corcept Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
7.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
560.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
378.5B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Corcept Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Corcept Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
